Related Experiment Video
Updated: Dec 31, 2025

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
Enrichment designs using placebo nonresponders.
Norbert Benda1,2, Britta Haenisch1,3,4
1Research Department, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
Enrichment designs using placebo nonresponders may not prove overall population efficacy due to potential selection bias. These designs are better suited for early-phase trials to show varying treatment effects.
Area of Science:
- Clinical trial design
- Psychopharmacology
- Statistical modeling
Background:
- Enrichment designs selecting placebo nonresponders are increasingly used in high placebo-response areas like depression.
- Sequential Parallel Design (SPD) re-randomizes nonresponders to placebo into a second phase with an enriched population.
Purpose of the Study:
- To analyze selection bias in enrichment designs that combine data from overall and enriched populations.
- To investigate the impact of subject-by-treatment interaction variability on bias.
- To provide sample sizes for detecting effects under specific conditions.
Main Methods:
- Theoretical analysis of bias in combined populations.
- Examination of the relationship between bias and subject-by-treatment interaction variability.
- Calculation of sample sizes for significance testing.
Main Results:
- Selection bias in enrichment designs is linked to the variability of subject-by-treatment interactions.
- If no subject-by-treatment interaction exists, enrichment designs are inefficient.
- Sample size calculations are provided for scenarios with zero average effect in the overall population.
Conclusions:
- Enrichment designs using placebo nonresponders cannot claim positive average effects in the overall population if subject-by-treatment interactions are present.
- These designs are unsuitable for pivotal Phase III trials aiming to demonstrate overall population efficacy.
- Enrichment designs may be valuable in early-phase trials for identifying heterogeneous treatment effects.
Related Concept Videos
The Placebo Effect
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Blind Procedures
Blinding
Dosage Regimens: Designs and Approaches
Group Design

